Healthcare Services

Syphilis Immunoassay Diagnostics Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 7, 2026April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Syphilis Immunoassay Diagnostics Market During The Forecast Period 2026–2030?

The syphilis immunoassay diagnostics market size has demonstrated significant growth in recent years. It is anticipated to expand from $33.5 billion in 2025 to $36.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be attributed to factors such as the increasing incidence of sexually transmitted infections, the enlargement of routine screening programs, improvements in laboratory infrastructure, the availability of ELISA and CLIA technologies, and a growing understanding of the importance of early syphilis diagnosis.

The syphilis immunoassay diagnostics market size is anticipated to experience robust growth in the near future, set to reach $46.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This expansion during the forecast period is fueled by factors such as the increasing uptake of rapid diagnostic tests, a growing emphasis on decentralized testing models, the broadening of screening programs in developing regions, increased investments in laboratory automation, and a heightened demand for high-throughput diagnostic platforms. Significant trends anticipated during this period encompass the greater adoption of automated immunoassay analyzers, an escalating demand for high-sensitivity diagnostic kits, the broadening of point-of-care syphilis testing, the increasing integration of digital laboratory workflows, and an intensified concentration on early and precise disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp

Which Major Factors Are Driving The Expansion Of The Syphilis Immunoassay Diagnostics Market?

An anticipated surge in sexually transmitted diseases is poised to fuel the expansion of the syphilis immunoassay diagnostics market in the coming years. Sexually transmitted infections (STIs), also referred to as STDs, are primarily spread through sexual contact, encompassing vaginal, anal, and oral sex. This rise in STDs is connected to various factors such as declining condom use, antibiotic resistance, inadequate sexual education, shifts in social and behavioral norms, associated stigma, reduced funding for STD programs, and heightened travel. Syphilis immunoassay diagnostics are instrumental in the detection and management of these infections by providing accurate and timely identification of syphilis, thus enabling appropriate treatment and prevention strategies. For instance, in June 2024, a report from the UK-based Terrence Higgins Trust revealed that the UK Health Security Agency (UKHSA) documented 401,800 sexually transmitted infections (STIs) in England in 2023, which represents a 5% rise compared to the prior year. This growing prevalence of sexually transmitted diseases is, therefore, driving the syphilis immunoassay diagnostics market.

What Market Segments Are Evaluated Within The Syphilis Immunoassay Diagnostics Market?

The syphilis immunoassay diagnostics market covered in this report is segmented –

1) By Product: Analyzers, Reagents, Kits, Other Products

2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies

3) By Application: Men, Women

4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users

Subsegments:

1) By Analyzers: Automated Analyzers, Semi-Automated Analyzers, Manual Analyzers

2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents, Chemiluminescent Immunoassay Reagents, Rapid Plasma Reagin Reagents, Treponemal And Non-Treponemal Reagents

3) By Kits: ELISA Kits, Rapid Diagnostic Test Kits, CLIA Kits, Point-Of-Care Test Kits

4) By Other Products: Control And Calibration Materials, Sample Collection Devices, Ancillary Testing Accessories

What Trends Are Affecting The Expansion Of The Syphilis Immunoassay Diagnostics Market?

Leading companies within the syphilis immunoassay diagnostics market are dedicated to developing inventive solutions, such as rapid syphilis tests, to boost the efficiency and accuracy of syphilis detection. These rapid syphilis tests are straightforward, point-of-care instruments that can detect syphilis antibodies in blood or bodily fluids within minutes, thereby enabling swift diagnosis and prompt treatment. For example, in February 2023, Chembio Diagnostics Inc., a US-based point-of-care diagnostics company specializing in infectious diseases, secured a CLIA waiver from the FDA for its DPP HIV-Syphilis System. The DPP HIV-Syphilis System is a dual rapid test designed for the simultaneous identification of antibodies to HIV 1/2 and Treponema pallidum, the bacterium that causes syphilis. This fast, 15-minute test aims to enhance diagnosis and treatment outcomes, especially in preventing mother-to-child transmission of syphilis and reducing the likelihood of HIV contraction among individuals with syphilis.

Who Are The Top Market Participants Influencing The Syphilis Immunoassay Diagnostics Market?

Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Meril Life Sciences Pvt Ltd, Randox Laboratories Ltd, SEKISUI Diagnostics, Trinity Biotech, Fujirebio, CTK Biotech Inc, bioLytical Laboratories Inc, ACON Laboratories Inc, InTec PRODUCTS INC, Quidel Corporation, Alere Inc, Ortho Clinical Diagnostics, DiaSorin Inc, Sekisui Medical, Beckman Coulter

Read the full syphilis immunoassay diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/syphilis-immunoassay-diagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Syphilis Immunoassay Diagnostics Market?

North America was the largest region in the syphilis immunoassay diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Syphilis Immunoassay Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16806&type=smp

Browse Through More Reports Similar to the Global Syphilis Immunoassay Diagnostics Market 2026, By The Business Research Company

Immunodiagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Infectious Disease Diagnostics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Diagnostic Specialty Antibodies Global Market Report

https://www.thebusinessresearchcompany.com/report/diagnostic-specialty-antibodies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795